Report Detail

Request for Sample of this report

Service & Software Global AI-driven Peptide Drug Discovery Platform Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4628867
    • |
  • 26 September, 2025
    • |
  • Global
    • |
  • 126 Pages
    • |
  • GIR
    • |
  • Service & Software

According to our latest research, the global AI-driven Peptide Drug Discovery Platform market size will reach USD 1347 million in 2031, growing at a CAGR of 9.0% over the analysis period.
AI-driven Peptide Drug Discovery Platforms are tools that use artificial intelligence (AI) technology to accelerate and optimize the discovery and development process of peptide drugs. These platforms typically combine computational biology, machine learning, deep learning and other technologies to improve the efficiency of identifying, designing, optimizing and validating drug candidate molecules.
The global AI-driven peptide drug R&D market is in a period of rapid growth, with the core driving force coming from the high failure rate of traditional peptide R&D (over 90% elimination rate in the preclinical stage) and the significant advantages of AI technology in reducing costs and increasing efficiency (shortening the early R&D cycle by 50%). North America occupies a dominant position (about 48% market share in 2023), mainly due to the concentration of leading companies such as Insilico Medicine and Schrödinger and active biopharmaceutical venture capital; the Asia-Pacific region has the fastest growth rate (CAGR of 29%), thanks to China's "14th Five-Year Plan for Bioeconomic Development" policy support for AI pharmaceuticals and technological breakthroughs by local companies such as Tai Technology. In the sub-sectors, tumor treatment (PDC drug development) and anti-infective drugs (antimicrobial peptide optimization) account for more than 60% of the market share, while metabolic diseases and neurological diseases have become emerging growth poles due to breakthroughs in GLP-1 analogs and blood-brain barrier penetration technology. The challenges faced by the industry are the low clinical conversion rate (only 7% of AI-designed drug candidates enter Phase II clinical trials) and data barriers (data closure of pharmaceutical companies limits model training), but the deepening cooperation between multinational pharmaceutical companies and AI platforms (such as Pfizer and Cyclica jointly developing peptide vaccines) is promoting the openness of the ecosystem. In the future, peptide-nucleic acid conjugates (PepRNA) and AI-driven fully automated laboratories (such as the Strateos cloud-based robotics platform) may reshape the industry's competitive landscape.
This report is a detailed and comprehensive analysis for global AI-driven Peptide Drug Discovery Platform market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI-driven Peptide Drug Discovery Platform market size and forecasts, in consumption value ($ Million), 2020-2031
Global AI-driven Peptide Drug Discovery Platform market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global AI-driven Peptide Drug Discovery Platform market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global AI-driven Peptide Drug Discovery Platform market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI-driven Peptide Drug Discovery Platform
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI-driven Peptide Drug Discovery Platform market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Peptilogics, Pepticom Ltd, Menten AI, GUBRA, Creative Peptides, Exscalate, Generate Biomedicines, Receptor.AI, Insilico Medicine, Schrödinger, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI-driven Peptide Drug Discovery Platform market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Design and Generation Platform
Screening and Optimization Platform
Data-driven Platform
Others
Market segment by Application
Scientific Research
Pharmaceuticals
Market segment by players, this report covers
Peptilogics
Pepticom Ltd
Menten AI
GUBRA
Creative Peptides
Exscalate
Generate Biomedicines
Receptor.AI
Insilico Medicine
Schrödinger
BenevolentAI
Evotec
PeptiFinder
Xtalpi
Sun Novo
Zonsen Peplib Biotech
Tide Tron Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI-driven Peptide Drug Discovery Platform product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI-driven Peptide Drug Discovery Platform, with revenue, gross margin, and global market share of AI-driven Peptide Drug Discovery Platform from 2020 to 2025.
Chapter 3, the AI-driven Peptide Drug Discovery Platform competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and AI-driven Peptide Drug Discovery Platform market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI-driven Peptide Drug Discovery Platform.
Chapter 13, to describe AI-driven Peptide Drug Discovery Platform research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of AI-driven Peptide Drug Discovery Platform by Type
    • 1.3.1 Overview: Global AI-driven Peptide Drug Discovery Platform Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Type in 2024
    • 1.3.3 Design and Generation Platform
    • 1.3.4 Screening and Optimization Platform
    • 1.3.5 Data-driven Platform
    • 1.3.6 Others
  • 1.4 Global AI-driven Peptide Drug Discovery Platform Market by Application
    • 1.4.1 Overview: Global AI-driven Peptide Drug Discovery Platform Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Scientific Research
    • 1.4.3 Pharmaceuticals
  • 1.5 Global AI-driven Peptide Drug Discovery Platform Market Size & Forecast
  • 1.6 Global AI-driven Peptide Drug Discovery Platform Market Size and Forecast by Region
    • 1.6.1 Global AI-driven Peptide Drug Discovery Platform Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global AI-driven Peptide Drug Discovery Platform Market Size by Region, (2020-2031)
    • 1.6.3 North America AI-driven Peptide Drug Discovery Platform Market Size and Prospect (2020-2031)
    • 1.6.4 Europe AI-driven Peptide Drug Discovery Platform Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size and Prospect (2020-2031)
    • 1.6.6 South America AI-driven Peptide Drug Discovery Platform Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Peptilogics
    • 2.1.1 Peptilogics Details
    • 2.1.2 Peptilogics Major Business
    • 2.1.3 Peptilogics AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.1.4 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Peptilogics Recent Developments and Future Plans
  • 2.2 Pepticom Ltd
    • 2.2.1 Pepticom Ltd Details
    • 2.2.2 Pepticom Ltd Major Business
    • 2.2.3 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.2.4 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Pepticom Ltd Recent Developments and Future Plans
  • 2.3 Menten AI
    • 2.3.1 Menten AI Details
    • 2.3.2 Menten AI Major Business
    • 2.3.3 Menten AI AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.3.4 Menten AI AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Menten AI Recent Developments and Future Plans
  • 2.4 GUBRA
    • 2.4.1 GUBRA Details
    • 2.4.2 GUBRA Major Business
    • 2.4.3 GUBRA AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.4.4 GUBRA AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 GUBRA Recent Developments and Future Plans
  • 2.5 Creative Peptides
    • 2.5.1 Creative Peptides Details
    • 2.5.2 Creative Peptides Major Business
    • 2.5.3 Creative Peptides AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.5.4 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Creative Peptides Recent Developments and Future Plans
  • 2.6 Exscalate
    • 2.6.1 Exscalate Details
    • 2.6.2 Exscalate Major Business
    • 2.6.3 Exscalate AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.6.4 Exscalate AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Exscalate Recent Developments and Future Plans
  • 2.7 Generate Biomedicines
    • 2.7.1 Generate Biomedicines Details
    • 2.7.2 Generate Biomedicines Major Business
    • 2.7.3 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.7.4 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Generate Biomedicines Recent Developments and Future Plans
  • 2.8 Receptor.AI
    • 2.8.1 Receptor.AI Details
    • 2.8.2 Receptor.AI Major Business
    • 2.8.3 Receptor.AI AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.8.4 Receptor.AI AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Receptor.AI Recent Developments and Future Plans
  • 2.9 Insilico Medicine
    • 2.9.1 Insilico Medicine Details
    • 2.9.2 Insilico Medicine Major Business
    • 2.9.3 Insilico Medicine AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.9.4 Insilico Medicine AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Insilico Medicine Recent Developments and Future Plans
  • 2.10 Schrödinger
    • 2.10.1 Schrödinger Details
    • 2.10.2 Schrödinger Major Business
    • 2.10.3 Schrödinger AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.10.4 Schrödinger AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Schrödinger Recent Developments and Future Plans
  • 2.11 BenevolentAI
    • 2.11.1 BenevolentAI Details
    • 2.11.2 BenevolentAI Major Business
    • 2.11.3 BenevolentAI AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.11.4 BenevolentAI AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 BenevolentAI Recent Developments and Future Plans
  • 2.12 Evotec
    • 2.12.1 Evotec Details
    • 2.12.2 Evotec Major Business
    • 2.12.3 Evotec AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.12.4 Evotec AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Evotec Recent Developments and Future Plans
  • 2.13 PeptiFinder
    • 2.13.1 PeptiFinder Details
    • 2.13.2 PeptiFinder Major Business
    • 2.13.3 PeptiFinder AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.13.4 PeptiFinder AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 PeptiFinder Recent Developments and Future Plans
  • 2.14 Xtalpi
    • 2.14.1 Xtalpi Details
    • 2.14.2 Xtalpi Major Business
    • 2.14.3 Xtalpi AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.14.4 Xtalpi AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Xtalpi Recent Developments and Future Plans
  • 2.15 Sun Novo
    • 2.15.1 Sun Novo Details
    • 2.15.2 Sun Novo Major Business
    • 2.15.3 Sun Novo AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.15.4 Sun Novo AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Sun Novo Recent Developments and Future Plans
  • 2.16 Zonsen Peplib Biotech
    • 2.16.1 Zonsen Peplib Biotech Details
    • 2.16.2 Zonsen Peplib Biotech Major Business
    • 2.16.3 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.16.4 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Zonsen Peplib Biotech Recent Developments and Future Plans
  • 2.17 Tide Tron Biotech
    • 2.17.1 Tide Tron Biotech Details
    • 2.17.2 Tide Tron Biotech Major Business
    • 2.17.3 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product and Solutions
    • 2.17.4 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Tide Tron Biotech Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global AI-driven Peptide Drug Discovery Platform Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of AI-driven Peptide Drug Discovery Platform by Company Revenue
    • 3.2.2 Top 3 AI-driven Peptide Drug Discovery Platform Players Market Share in 2024
    • 3.2.3 Top 6 AI-driven Peptide Drug Discovery Platform Players Market Share in 2024
  • 3.3 AI-driven Peptide Drug Discovery Platform Market: Overall Company Footprint Analysis
    • 3.3.1 AI-driven Peptide Drug Discovery Platform Market: Region Footprint
    • 3.3.2 AI-driven Peptide Drug Discovery Platform Market: Company Product Type Footprint
    • 3.3.3 AI-driven Peptide Drug Discovery Platform Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global AI-driven Peptide Drug Discovery Platform Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global AI-driven Peptide Drug Discovery Platform Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global AI-driven Peptide Drug Discovery Platform Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2031)
  • 6.2 North America AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2031)
  • 6.3 North America AI-driven Peptide Drug Discovery Platform Market Size by Country
    • 6.3.1 North America AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2031)
    • 6.3.2 United States AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
    • 6.3.3 Canada AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2031)
  • 7.2 Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2031)
  • 7.3 Europe AI-driven Peptide Drug Discovery Platform Market Size by Country
    • 7.3.1 Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2031)
    • 7.3.2 Germany AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
    • 7.3.3 France AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
    • 7.3.5 Russia AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
    • 7.3.6 Italy AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Region
    • 8.3.1 Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Region (2020-2031)
    • 8.3.2 China AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
    • 8.3.3 Japan AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
    • 8.3.5 India AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
    • 8.3.7 Australia AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2031)
  • 9.2 South America AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2031)
  • 9.3 South America AI-driven Peptide Drug Discovery Platform Market Size by Country
    • 9.3.1 South America AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country
    • 10.3.1 Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
    • 10.3.4 UAE AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 AI-driven Peptide Drug Discovery Platform Market Drivers
  • 11.2 AI-driven Peptide Drug Discovery Platform Market Restraints
  • 11.3 AI-driven Peptide Drug Discovery Platform Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 AI-driven Peptide Drug Discovery Platform Industry Chain
  • 12.2 AI-driven Peptide Drug Discovery Platform Upstream Analysis
  • 12.3 AI-driven Peptide Drug Discovery Platform Midstream Analysis
  • 12.4 AI-driven Peptide Drug Discovery Platform Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on AI-driven Peptide Drug Discovery Platform. Industry analysis & Market Report on AI-driven Peptide Drug Discovery Platform is a syndicated market report, published as Global AI-driven Peptide Drug Discovery Platform Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of AI-driven Peptide Drug Discovery Platform market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo